Austin, TX·Biotechnology, Banking, Manufacturing·Last fund filed May 2010
Funds on file
1
Partners named
15
15 on a current fund
Recent board seats
10
last 24 months
Capital raised
$2.1B
across filed funds
What has Vida Longevity raised?
1 vehicle
Vehicle
Filed
Target
Sold to date
Investors
Vida Longevity Fund, LP
May 2010
Indefinite
$2.1B
4,919
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
Who at Vida Longevity can lead a round?
15 named
15 partners are named across this firm’s filings, 15 of them on a fund it is deploying now.
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Data & analytics2 · 5%
Digital health2 · 5%
Logistics & supply chain2 · 5%
Real estate & proptech2 · 5%
Sales & marketing tech2 · 5%
AI & machine learning1 · 2%
Developer tools & infrastructure1 · 2%
E-commerce & marketplaces1 · 2%
Education1 · 2%
Fintech1 · 2%
Food & agriculture1 · 2%
Gaming & entertainment1 · 2%
Healthcare services1 · 2%
Mobility & transportation1 · 2%
Robotics & hardware1 · 2%
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Vida Longevity’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
A shared board seat: a company where filings name a Vida Longevity partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.